CID 6505368

Brivudine monophosphate

Structural Information

Molecular Formula
C11H14BrN2O8P
SMILES
C1[C@@H]([C@H](O[C@H]1N2C=C(C(=O)NC2=O)/C=C/Br)COP(=O)(O)O)O
InChI
InChI=1S/C11H14BrN2O8P/c12-2-1-6-4-14(11(17)13-10(6)16)9-3-7(15)8(22-9)5-21-23(18,19)20/h1-2,4,7-9,15H,3,5H2,(H,13,16,17)(H2,18,19,20)/b2-1+/t7-,8+,9+/m0/s1
InChIKey
LKWCVKAHHUJPQO-PIXDULNESA-N
Compound name
[(2R,3S,5R)-5-[5-[(E)-2-bromoethenyl]-2,4-dioxopyrimidin-1-yl]-3-hydroxyoxolan-2-yl]methyl dihydrogen phosphate
Related CIDs

2D Structure

compound 2d structure
1
Annotation Hits

5
References

59
Patents

411.9671 Da
Monoisotopic Mass

-2.1
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 412.97438 184.6
[M+Na]+ 434.95632 194.1
[M-H]- 410.95982 186.1
[M+NH4]+ 430.00092 194.4
[M+K]+ 450.93026 183.6
[M+H-H2O]+ 394.96436 181.0
[M+HCOO]- 456.96530 200.7
[M+CH3COO]- 470.98095 206.4
[M+Na-2H]- 432.94177 184.1
[M]+ 411.96655 203.3
[M]- 411.96765 203.3
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

patents stripe